Acasti Pharma Inc (ACST) Stock
ACST is no longer traded. Acasti Pharma was delisted from the Nasdaq in October 2024.
Prices on this page are historical; the last trade was October 25, 2024 at $3.37.
Acasti Pharma stock price history
ACST final trading statistics
- Final close
- $3.37
- Final trading day
- Oct 25, 2024
- Market cap at delisting
- $34.17M
- Shares outstanding
- 10.14M
- Final 52-week range
- $1.98 – $3.60
- Avg. volume (final 3 mo.)
- 27,650
- All-time high (split-adj.)
- $1953.60 · Aug 2013
- All-time low (split-adj.)
- $1.77 · Sep 2023
- Return since IPO
- -99.4%
- Beta
- 1.52
- Book value / share
- $5.86
- Price / book
- 0.58
Acasti Pharma annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$12.9M | -$1.45 |
| FY2023 | $0.00 | -$42.4M | -$4.20 |
| FY2022 | $13.0K | -$9.8M | -$0.31 |
| FY2021 | $196.0K | -$19.7M | -$0.92 |
| FY2020 | $0.00 | -$25.8M | -$2.12 |
Last five fiscal years reported before the delisting; fiscal year ending March. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Acasti Pharma Inc
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Acasti Pharma stock FAQ
What happened to Acasti Pharma stock?
Acasti Pharma stock was delisted from the Nasdaq. Its final close was $3.37 on October 25, 2024.
Is ACST stock still trading?
No. ACST was delisted from the Nasdaq in October 2024 and no longer trades on a U.S. exchange.
What was the last price of ACST stock?
ACST closed at $3.37 on its final trading day, October 25, 2024, for a market value of about $34.17M.
What were Acasti Pharma's revenue and earnings in its last full fiscal year?
Acasti Pharma reported revenue of $0.00 and net income of -$12.9M in fiscal 2024, its last full year as a public company.
When did Acasti Pharma go public?
Acasti Pharma Inc stock began trading on May 6, 2011.